Literature DB >> 3725419

The classification of malignant melanoma, its histological reporting and registration: a revision of the 1972 Sydney classification.

V J McGovern, A J Cochran, E P Van der Esch, J H Little, R MacLennan.   

Abstract

A group of pathologists with an interest in malignant melanoma met in Sydney in 1982 to update the classification of melanoma formulated in Sydney in 1972. The group recommended that malignant melanoma be classified as follows: malignant melanoma with an adjacent component of superficial spreading type, malignant melanoma with an adjacent component of lentigo maligna type, malignant melanoma with an adjacent component of acral lentiginous type, malignant melanoma with an adjacent component of mucosal lentiginous type, malignant melanoma with no adjacent component, malignant melanoma of unclassifiable histogenetic type. The data recorded in the surgical pathology report should include: diagnosis of primary malignant melanoma, histogenetic classification, presence/absence of ulceration, micrometer-measured thickness, microanatomical level, mitotic rate/mm2, presence/absence of vascular invasion, presence/absence of regression, completeness of resection. The recommendations for the examination of specimens and the recording of data for research purposes and for tumour registries are described.

Entities:  

Mesh:

Year:  1986        PMID: 3725419     DOI: 10.3109/00313028609090822

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  16 in total

1.  Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.

Authors:  John F Thompson; Seng-Jaw Soong; Charles M Balch; Jeffrey E Gershenwald; Shouluan Ding; Daniel G Coit; Keith T Flaherty; Phyllis A Gimotty; Timothy Johnson; Marcella M Johnson; Stanley P Leong; Merrick I Ross; David R Byrd; Natale Cascinelli; Alistair J Cochran; Alexander M Eggermont; Kelly M McMasters; Martin C Mihm; Donald L Morton; Vernon K Sondak
Journal:  J Clin Oncol       Date:  2011-04-25       Impact factor: 44.544

2.  A new animal model for the imaging of melanoma: correlation of FDG PET with clinical outcome, macroscopic aspect and histological classification in Melanoblastoma-bearing Libechov Minipigs.

Authors:  Raphaël Boisgard; Silvia Vincent-Naulleau; Jean-Jacques Leplat; Stephan Bouet; Catherine Le Chalony; Yves Tricaud; Vratislav Horak; Claudine Geffrotin; Gérard Frelat; Bertrand Tavitian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-08       Impact factor: 9.236

Review 3.  Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care.

Authors:  Richard A Scolyer; Georgina V Long; John F Thompson
Journal:  Mol Oncol       Date:  2011-03-21       Impact factor: 6.603

4.  Epithelioid cell melanomas have greater DNA ploidy abnormalities than spindle cell melanomas: cytological evidence for a higher malignant potential of the former.

Authors:  H I Chi; Y Uyeda; Y Umebayashi; F Otsuka
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

5.  Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma.

Authors:  William F Anderson; Ruth M Pfeiffer; Margaret A Tucker; Philip S Rosenberg
Journal:  Cancer       Date:  2009-09-15       Impact factor: 6.860

6.  Malignant melanomas of the oral cavity: heterogeneity of pathological and clinical features.

Authors:  K Ohashi; T Kasuga; N Tanaka; S Enomoto; J Horiuchi; N Okada
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

7.  Breslow thickness of cutaneous malignant melanoma in paraffin wax and frozen sections.

Authors:  N Kirkham; K Blessing; B Gibson; M L Price
Journal:  J Clin Pathol       Date:  1991-08       Impact factor: 3.411

Review 8.  Melanocytic nevi simulant of melanoma with medicolegal relevance.

Authors:  Guido Massi
Journal:  Virchows Arch       Date:  2007-07-26       Impact factor: 4.064

9.  Treatment of cutaneous melanoma: current approaches and future prospects.

Authors:  Alain P Algazi; Christopher W Soon; Adil I Daud
Journal:  Cancer Manag Res       Date:  2010-08-17       Impact factor: 3.989

10.  Biomarkers as key contributors in treating malignant melanoma metastases.

Authors:  Camila Ferreira de Souza; Alice Santana Morais; Miriam Galvonas Jasiulionis
Journal:  Dermatol Res Pract       Date:  2011-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.